Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1969 1
1971 1
1975 1
1977 1
1978 3
1979 5
1981 2
1982 5
1983 4
1984 4
1985 2
1986 3
1987 5
1988 2
1989 5
1990 1
1991 1
1992 1
1993 3
1994 6
1995 4
1996 10
1997 7
1998 4
1999 11
2000 5
2001 9
2002 6
2003 8
2004 9
2005 7
2006 9
2007 14
2008 11
2009 13
2010 19
2011 23
2012 17
2013 16
2014 16
2015 21
2016 16
2017 9
2018 7
2019 5
2020 5
2021 3
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

310 results
Results by year
Filters applied: . Clear all
Page 1
Agalsidase-beta therapy for advanced Fabry disease: a randomized trial.
Banikazemi M, Bultas J, Waldek S, Wilcox WR, Whitley CB, McDonald M, Finkel R, Packman S, Bichet DG, Warnock DG, Desnick RJ; Fabry Disease Clinical Trial Study Group. Banikazemi M, et al. Among authors: warnock dg. Ann Intern Med. 2007 Jan 16;146(2):77-86. doi: 10.7326/0003-4819-146-2-200701160-00148. Epub 2006 Dec 18. Ann Intern Med. 2007. PMID: 17179052 Free article. Clinical Trial.
Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease.
Germain DP, Charrow J, Desnick RJ, Guffon N, Kempf J, Lachmann RH, Lemay R, Linthorst GE, Packman S, Scott CR, Waldek S, Warnock DG, Weinreb NJ, Wilcox WR. Germain DP, et al. Among authors: warnock dg. J Med Genet. 2015 May;52(5):353-8. doi: 10.1136/jmedgenet-2014-102797. Epub 2015 Mar 20. J Med Genet. 2015. PMID: 25795794 Free PMC article. Clinical Trial.
Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data.
Matsushita K, Coresh J, Sang Y, Chalmers J, Fox C, Guallar E, Jafar T, Jassal SK, Landman GW, Muntner P, Roderick P, Sairenchi T, Schöttker B, Shankar A, Shlipak M, Tonelli M, Townend J, van Zuilen A, Yamagishi K, Yamashita K, Gansevoort R, Sarnak M, Warnock DG, Woodward M, Ärnlöv J; CKD Prognosis Consortium. Matsushita K, et al. Among authors: warnock dg. Lancet Diabetes Endocrinol. 2015 Jul;3(7):514-25. doi: 10.1016/S2213-8587(15)00040-6. Epub 2015 May 28. Lancet Diabetes Endocrinol. 2015. PMID: 26028594 Free PMC article.
Hypertension.
Warnock DG, Textor SC. Warnock DG, et al. Am J Kidney Dis. 2004 Aug;44(2):369-75. doi: 10.1053/j.ajkd.2004.06.002. Am J Kidney Dis. 2004. PMID: 15264197 Review. No abstract available.
Hyperkalemia.
Alvo M, Warnock DG. Alvo M, et al. Among authors: warnock dg. West J Med. 1984 Nov;141(5):666-71. West J Med. 1984. PMID: 6516337 Free PMC article.
Uremic acidosis.
Warnock DG. Warnock DG. Kidney Int. 1988 Aug;34(2):278-87. doi: 10.1038/ki.1988.177. Kidney Int. 1988. PMID: 3054224 Free article. Review. No abstract available.
A Meta-analysis of the Association of Estimated GFR, Albuminuria, Diabetes Mellitus, and Hypertension With Acute Kidney Injury.
James MT, Grams ME, Woodward M, Elley CR, Green JA, Wheeler DC, de Jong P, Gansevoort RT, Levey AS, Warnock DG, Sarnak MJ; CKD Prognosis Consortium. James MT, et al. Among authors: warnock dg. Am J Kidney Dis. 2015 Oct;66(4):602-12. doi: 10.1053/j.ajkd.2015.02.338. Epub 2015 May 11. Am J Kidney Dis. 2015. PMID: 25975964 Free PMC article. Review.
K-Cl cotransport systems.
Warnock DG, Eveloff J. Warnock DG, et al. Kidney Int. 1989 Sep;36(3):412-7. doi: 10.1038/ki.1989.210. Kidney Int. 1989. PMID: 2687568 Free article. Review.
310 results